【レポートの概要(一部)】
1 Introduction (Page No. – 20)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency Used for the Study
1.5 Major Market Stakeholders
2 Research Methodology (Page No. – 23)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.2 Market Estimation Methodology
2.2.1 End User-Based Market Estimation
2.2.2 Revenue Mapping-Based Market Estimation
2.2.3 Primary Research Validation
2.3 Data Triangulation
2.4 Research Assumptions
2.5 Research Limitations
3 Executive Summary (Page No. – 31)
4 Premium Insights (Page No. – 35)
4.1 Market Overview
4.2 Neurodiagnostics Market, By Product, 2019 Vs. 2024
4.3 Market Share, By End User and Region (2019)
4.4 Market, By Condition, 2019 Vs. 2024 (USD Million)
4.5 Market, By Country
5 Market Overview (Page No. – 40)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Prevalence of Neurological Diseases & Disorders
5.2.1.2 Technological Advancements
5.2.1.3 Growing Patient Emphasis on Effective and Early Disease Diagnosis
5.2.1.4 Increasing Number of Diagnostic Centers & Hospitals
5.2.1.5 Advances in Genomics and Proteomics for the Diagnosis of Neurodegenerative Disorders
5.2.2 Restraints
5.2.2.1 High Cost of Neurodiagnostic Devices
5.2.2.2 Growing Adoption of Refurbished Neurodiagnostic Systems
5.2.3 Opportunities
5.2.3.1 Increasing Application in Clinical Trials
5.2.3.2 Emerging Markets
5.2.4 Challenges
5.2.4.1 Dearth of Skilled Surgeons
6 Neurodiagnostics Market, By Product (Page No. – 46)
6.1 Introduction
6.2 Diagnostic Imaging Systems
6.2.1 Growing Number of Diagnostic Laboratories & Imaging Centers to Drive the Adoption of Diagnostic Imaging Systems
6.2.1.1 MRI Systems
6.2.1.2 EEG Systems
6.2.1.3 CT Scanners
6.2.1.4 PET Scanners
6.2.1.5 EMG Devices
6.2.1.6 Ultrasound Imaging Systems
6.2.1.7 MEG Devices
6.2.1.8 Angiography Systems
6.2.1.9 Other Diagnostic Imaging Systems
6.3 Clinical Diagnostic Instruments
6.3.1 Increasing Public-Private Investments are Supporting the Growth of This Market Segment
6.3.1.1 PCR Instruments
6.3.1.2 NGS Instruments
6.3.1.3 Sanger Sequencers
6.3.1.4 Other Clinical Diagnostic Instruments
6.4 Reagents & Consumables
6.4.1 High Consumption of Reagents in Various Routine Assays & Techniques is Driving the Growth of This Segment
6.4.1.1 Media & Sera
6.4.1.2 Antibodies
6.4.1.3 Buffers
6.4.1.4 Solvents
6.4.1.5 Enzymes, Proteins, & Peptides
6.4.1.6 Probes
6.4.1.7 Other Reagents & Consumables
7 Neurodiagnostics Market, By Condition (Page No. – 87)
7.1 Introduction
7.2 Neurodegenerative Diseases
7.2.1 Growing Number of Neurological Examinations is Supporting the Growth of This Segment
7.3 Stroke
7.3.1 Growing Awareness About Strokes & Its Treatment Options in the Market are Supporting Market Growth
7.4 Epilepsy
7.4.1 Favorable Government Initiatives Have Resulted in the Increased Adoption of Neurodiagnostic Products
7.5 Headache Disorders
7.5.1 Increasing Incidence of Migraines & Tension Headaches to Support Market Growth
7.6 Sleep Disorders
7.6.1 Increasing Stress & Unhealthy Lifestyles are Supporting the Growth of This Market Segment
8 Neurodiagnostics Market, By End User (Page No. – 95)
8.1 Introduction
8.2 Hospitals & Surgical Centers
8.2.1 Hospitals & Surgical Centers are the Major End Users of Neurodiagnostic Devices Owing to Their High Purchasing Power to Buy Expensive Equipment
8.3 Diagnostic Laboratories & Imaging Centers
8.3.1 Growing Number of Private Imaging Centers Supports the Growth of This End-User Segment
8.4 Neurology Centers
8.4.1 Lower Costs and Shorter Waiting Periods Compared to Hospitals to Drive Market Growth
8.5 Ambulatory Care Centers
8.5.1 High-Quality and Lower-Cost Services Offered By Ambulatory Care Centers to Drive Market Growth
8.6 Research Laboratories & Academic Institutes
8.6.1 Budgetary Limitations Faced By Small Research Laboratories & Academic Institutes Will Restrain Market Growth
9 Neurodiagnostics Market, By Region (Page No. – 102)
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US Dominates the Market Due to the Increased Adoption of High-End Neurodiagnostic Systems
9.2.2 Canada
9.2.2.1 Favorable Environment for R&D in the Field of Neurosciences is Driving Market Growth
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany Commands the Largest Share of the Neurodiagnostics Market in Europe
9.3.2 UK
9.3.2.1 Market Growth in the UK is Mainly Driven By the Increasing Incidence of Neurodegenerative Diseases
9.3.3 France
9.3.3.1 Increasing Healthcare Expenditure Coupled With the High-End Medical Infrastructure Will Drive Demand for Neurodiagnostic Devices
9.3.4 Italy
9.3.4.1 Ongoing Economic Crisis in the Country and Rising Government Pressure to Reduce Healthcare Costs May Slow Market Growth
9.3.5 Spain
9.3.5.1 Increased Cost Burden on the State-Run Health Insurance System Will Hinder Market Growth
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.1.1 Favorable Reimbursement and Growing Neurological Disorder Patients Have Propelled Market Growth in Japan
9.4.2 China
9.4.2.1 Government Initiatives to Modernize Healthcare Facilities and the Rising Geriatric Population Will Drive Market Growth
9.4.3 India
9.4.3.1 Low Entry Barriers Have Made India a Prominent Market to Invest In
9.4.4 Australia
9.4.4.1 Technology Advancements and Improving Healthcare Infrastructure Will Drive the Market in Australia
9.4.5 South Korea
9.4.5.1 Rising Healthcare Spending and Medical Coverage for Neurological Disease Treatment Will Propel the Market Growth
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.1.1 Inadequate Accessibility to Healthcare has Driven the Government to Undertake Corrective Measures
9.5.2 Mexico
9.5.2.1 Mexico is a Prominent Medical Tourism Hub for US Patients
9.5.3 Rest of Latin America
9.6 Middle East & Africa
9.6.1 Infrastructural Development and Growing Healthcare Expenditure Will Contribute to Market Growth in the MEA
10 Competitive Landscape (Page No. – 165)
10.1 Overview
10.2 Market Share Analysis
10.3 Competitive Scenario
10.3.1 Key Product Launches
10.3.2 Key Expansions
10.3.3 Key Acquisitions
10.3.4 Key Partnerships, Agreements, and Collaborations
10.4 Competitive Leadership Mapping
10.4.1 Visionary Leaders
10.4.2 Innovators
10.4.3 Dynamic Differentiators
10.4.4 Emerging Companies
11 Company Profiles (Page No. – 172)
(Business Overview, Products Offered, Recent Developments, MnM View)*
11.1 GE Healthcare
11.2 Philips Healthcare
11.3 Siemens Healthineers
11.4 Hitachi, Ltd.
11.5 Canon, Inc.
11.6 Lifelines Neuro Company, LLC
11.7 Natus Medical Incorporated
11.8 F. Hoffmann-La Roche AG
11.9 FUJIFILM Holdings Corporation
11.10 Mitsar Co., Ltd.
11.11 Advanced Brain Monitoring, Inc.
11.12 Thermo Fisher Scientific, Inc.
11.13 Bio-Rad Laboratories
11.14 QIAGEN N.V.
11.15 Nihon Kohden Corporation
11.16 Other Companies
11.16.1 ANT Neuro
11.16.2 Fonar Corporation
11.16.3 Fujirebio (A Part of Miraca Group)
11.16.4 DRG Instruments GmbH
11.16.5 Tecan Trading AG
*Business Overview, Products Offered, Recent Developments, MnM View Might Not be Captured in Case of Unlisted Companies.
12 Appendix (Page No. – 213)
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details
【レポート販売概要】
■ タイトル:世界の神経診断市場:製品別(診断および画像システム(MRI、超音波)、臨床検査(PCR、NGS)、試薬および消耗品)、疾患病理学別(てんかん、脳卒中)、エンドユーザー別、地域別■ 英文:Neurodiagnostics Market by Product (Diagnostic & Imaging Systems (MRI, Ultrasound), Clinical Testing (PCR, NGS), Reagents & Consumables), Disease Pathology (Epilepsy, Stroke), End User, and Region - Global Forecast to 2024
■ 発行日:2019年12月9日
■ 調査会社:MarketsandMarkets
■ 商品コード:MD 7460
■ 調査対象地域:グローバル
- 世界主要国におけるはしか検査市場2015The report presents a detailed analysis of the Measles diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Measles definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments: - Hospitals - Commerc …
- コンプレッサ制御装置の世界市場ABSTRACTAbout Compressor Control Systems Compressor control systems are mainly used to control compressors and improve their efficiency. Hardware components used in compressors send signals and data to software applications, which help in controlling functionalities of compressors. Hardware components are extensively used as these act as the basic elements to support the functionalities of compres …
- 電子走査アレイの世界市場予測:アクティブ電子走査アレイ(AESA)、パッシブ電子走査アレイ(PESA)The electronically scanned arrays market is projected to grow from USD 6.24 Billion in 2016 to USD 8.43 Billion by 2021, at a CAGR of 6.20% during the forecast period. Replacement of traditional electronically scanned array systems and integration of active electronically scanned arrays with traditional radar system components are key factors expected to drive the growth of the electronically scan …
- 黄斑浮腫(Macular Edema)治療のグローバル市場(2014-2018)About Macular Edema Macular edema results from fluid accumulation in the macular region of the retina. Macular edema arises from various etiologies such as diabetes, AMD, and RVO. Macular edema disrupts the central vision due to swelling of the macula. Currently, the treatment plan involves the use of surgical and laser therapies as well as drugs such as anti-VEGF therapies and NSAIDs. Surgery and …
- 金融産業向けサイバーセキュリティ・ソリューションの世界市場2015-2019About Cyber Security Cyber threats are web-based threats such as data thefts and identity thefts. They disrupt IT systems in organizations and hack critical information using malware, spyware, or by phishing. Cyber security solutions help organizations in the BFSI sector to report, monitor, detect, and counter cyber threats while maintaining the confidentiality of information systems. In addition, …
- 糖尿病性神経障害(Diabetic Neuropathy)のグローバル市場(2014-2018)About Diabetic Neuropathy Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below norma …
- 民間航空機オートパイロットシステム(自動操縦装置)の世界市場About commercial aircraft autopilot systems Autopilot systems operate, control, and monitor aircraft without constant supervision by the pilot. They consist of four major components: computer systems, actuators, gyros, and GPS. Computer systems allow pilots to program the autopilot system, helps them interact with the GPS and gyros, and transfers the information to an actuator. Autopilot systems e …
- Qiagen N.V:市場シェア分析Qiagen N.V Market Share Analysis Summary GlobalData’s new report, “Qiagen N.V. Market Share Analysis” provides in-depth information on Qiagen N.V.’s market position in the different medical equipment markets it operates in. The report provides Qiagen N.V. market share information in two key market categories – Infectious Immunology and Genetic Testing. The report also provides data and information …
- 世界の政府部門におけるバイオメトリクス認証支出市場About biometrics spending in the government sector Security of data and assets has been a key concern for enterprises, banks, government organizations, telecommunications, hospitals, as well as individuals. Keys, identity badges, and numeric keypads were previously being used to prevent unauthorised access. Technological advancements resulted in the introduction of two-factor authentication, where …
- 軍事シミュレーション・軍事訓練の世界市場予測(~2021年)The military simulation and training market is projected to grow from USD 10.31 Billion in 2016 to USD 12.67 Billion by 2021, at a CAGR of 4.20% during the forecast period. Factors, such as increasing political disputes and civil unrest, adoption of virtual training to ensure safety and cost-benefits, and decline in military budgets of developed countries are driving the growth of the military sim …
- 下肢用末梢血管ステント:企業と競争環境MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players Summary GlobalData has released its medical devices report, “MediPoint: Peripheral Vascular Stents for the Lower Extremity - Current and Future Players”. The report is an essential source of information and analysis on the global Peripheral Vascular Stent (PVS) market. Through GlobalData’s analysis, it is ev …
- アフターサンケア製品の世界市場:プライスポイント別(マスアフターサン、プレミアムアフターサン)、フォーム別(クリーム、ジェル、ローション、エッセンシャルオイル、その他)、流通経路別(小売薬局、コンビニエンスストア、スーパーマーケット/ハイパーマーケット、Eコマース)After sun care products are used in rehydrating sun burnt skin and are sold in various form such as cream, oil, lotion, and powder. These products are sold through various supply chains such as, retail pharmacies, convenience stores, supermarket/hypermarket and e-commerce. The current scope of the report considers various after sun care products which are sold at mass as well as premium price poin …
- 中国のフレキシブルパッケージ市場The flexible packaging market in China is expected to grow moderately during the forecast period. Technavio market research analysts predict the flexible packaging market in China to post a CAGR of close to 8% over the next four years. One of the major reason for the growth of this market in China is increased economic development in the country. In terms of sales revenue, China is the dominant co …
- エポキシ接着剤の世界市場予測(~2026):種類別、用途別(建物&建設、交通、自動車、風力エネルギー、船舶、電気&電子)、地域別The global epoxy adhesives market is estimated to reach USD 10.13 Billion by 2026, at a CAGR of 6.63% from 2016 to 2026. The growing urbanization due to the improved living standards, and increase in usage of composites, plastics and other higher strength metals in the construction industry and the ability of epoxy adhesives to adhere strongly, with the exceptional mechanical & electrical insulati …
- ホスフィン燻蒸剤の世界市場予測(~2022年):リン化アルミニウム、リン化マグネシウム、リン化カルシウム“Phosphine fumigation market projected to grow at a CAGR of 5.49% from 2017 to 2022”The phosphine fumigation market is projected to reach USD 698.0 million by 2022 at a CAGR of 5.49% from 2017. The market is driven by factors such as increase in awareness about advanced modes of application of fumigation technology, increasing insect population due to climatic changes, and phasing out of methyl br …